Featured Insights and Perspectives from BCG

Understanding how diseases work in the body is central to discovering new medicines, and remains one of biology’s greatest challenges, a problem at the core of biomedical research. To tackle this, Merck & Co., in collaboration with the BCG X Al Science Institute, developed a new family of foundation models: TEDDY (Transformers for Enabling Drug DiscoverY). TEDDY aims to advance how machine learning is used to understand disease biology.

Mastercard’s Cheryl Guerin shares how listening to consumers and acting on their insights helps the company deliver unique experiences and build brand loyalty.

Diageo's Liubov Ruchinskaya, founder of Insights Lighthouse, says it’s time for consumer insights professionals to evolve into human intelligence experts.

Sanjna Parulekar from Salesforce and BCG’s Bryan Gauch say companies need to focus on the basics—people, processes, and data—to scale AI.

Maya Said of Outcomes4Me says being transparent about the business and providing evidence-based information are critical to scaling a patient-empowerment platform.

After a year of record growth, asset managers must shift to a more diversified mindset amidst growing uncertainty, say BCG’s Pete Czerepak and Renaud Fages.

Rather than optimizing isolated tasks, companies must transform ways of working and break down organizational silos.

Although dealmaking conditions have undeniably grown more challenging in recent years, the long-term drivers of M&A remain in place.